Fig. 4
From: Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
a A Kaplan-Meier plot demonstrates that the overall survival rate was significantly higher in hepatoblastoma patients with an age at diagnosis ≦ 1.25 years compared with the those with diagnostic age > 1.25 years (P = 0.03). b The native liver survival rate was significantly higher in patients with hepatoblastoma and an age at diagnosis ≦ 1.25 years compared with the those with diagnostic age > 1.25 years (P = 0.007). c The overall survival rate was significantly higher in patients with hepatoblastoma and serum alpha-fetoprotein levels <1200 ng/mL compared with those with serum alpha-fetoprotein levels ≧ 1200 ng/mL after neuadjuvant chemotherapy (P = 0.01). d The native liver survival rate was significantly higher in patients with hepatoblastoma and serum alpha-fetoprotein levels <1200 ng/mL compared with those with serum alpha-fetoprotein levels≧ 1200 ng/mL after neuadjuvant chemotherapy (P = 0.004)